Related Content
Search Google Scholar for:
|
|
Science 15 November 1985: Vol. 230. no. 4727, pp. 777 - 783 DOI: 10.1126/science.2997918
|
|
Articles
Science, Vol 230, Issue 4727, 777-783
Copyright © 1985 by American Association for the Advancement of Science
Histocompatibility antigens on murine tumors
RS Goodenow,
JM Vogel,
and
RL Linsk
Recent advances in tumor immunology suggest that the expression of the histocompatibility antigens, encoded by the major histocompatibility complex, is important in controlling the metastatic growth of certain murine tumors. The anomalous expression of histocompatibility antigens in many neoplasms appears to be associated with the ability of these cells to evade the immune system and progress to metastasis. This review examines some of the underlying molecular and immunobiological interactions that might determine the metastatic outcome of cellular transformation.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Activation and Potentiation of Interferon-{gamma} Signaling by 3,3'-Diindolylmethane in MCF-7 Breast Cancer Cells.
- J. E. Riby, L. Xue, U. Chatterji, E. L. Bjeldanes, G. L. Firestone, and L. F. Bjeldanes (2006)
Mol. Pharmacol.
69, 430-439
| Abstract »
| Full Text »
| PDF »
- HER-2/neu-Mediated Regulation of Components of the MHC Class I Antigen-Processing Pathway.
- F. Herrmann, H.-A. Lehr, I. Drexler, G. Sutter, J. Hengstler, U. Wollscheid, and B. Seliger (2004)
Cancer Res.
64, 215-220
| Abstract »
| Full Text »
| PDF »
- Phase II Study of Direct Intralesional Gene Transfer of Allovectin-7, an HLA-B7/{beta}2-Microglobulin DNA-Liposome Complex, in Patients with Metastatic Melanoma.
- A. T. Stopeck, A. Jones, E. M. Hersh, J. A. Thompson, D. M. Finucane, J. C. Gutheil, and R. Gonzalez (2001)
Clin. Cancer Res.
7, 2285-2291
| Abstract »
| Full Text »
| PDF »
- Characterization of the Major Histocompatibility Complex Class I Deficiencies in B16 Melanoma Cells.
- B. Seliger, U. Wollscheid, F. Momburg, T. Blankenstein, and C. Huber (2001)
Cancer Res.
61, 1095-1099
| Abstract »
| Full Text »
- The Level of MHC Class I Expression on Murine Adenocarcinoma Can Change the Antitumor Effector Mechanism of Immunocytokine Therapy.
- M. Imboden, K. R. Murphy, A. L. Rakhmilevich, Z. C. Neal, R. Xiang, R. A. Reisfeld, S. D. Gillies, and P. M. Sondel (2001)
Cancer Res.
61, 1500-1507
| Abstract »
| Full Text »
- HLA-DR and {beta}2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.
- M. Feinmesser, A. Sulkes, S. Morgenstern, J. Sulkes, S. Stern, and E. Okon (2000)
J. Clin. Pathol.
53, 286-291
| Abstract »
| Full Text »
| PDF »
- Feline Leukemia Virus Long Terminal Repeat Activates Collagenase IV Gene Expression through AP-1.
- S. K. Ghosh and D. V. Faller (1999)
J. Virol.
73, 4931-4940
| Abstract »
| Full Text »
- MHC Class I Heavy Chain mRNA Must Exceed a Threshold Level for the Reconstitution of Cell Surface Expression of Class I MHC Complexes in Cells Transformed by the Highly Oncogenic Adenovirus 12.
- S. V. Fromm, S. W. Mey-Tal, J. E. Coligan, C. Schechter, and R. Ehrlich (1998)
J. Biol. Chem.
273, 15209-15216
| Abstract »
| Full Text »
| PDF »
- Synthesis and Turnover of beta 2-Microglobulin in Ad12-transformed Cells Defective in Assembly and Transport of Class I Major Histocompatibility Complex Molecules.
- S. V. Mey-Tal, C. Schechter, and R. Ehrlich (1997)
J. Biol. Chem.
272, 353-361
| Abstract »
| Full Text »
| PDF »
- Genetic Analysis of a Sarcoma Accidentally Transplanted from a Patient to a Surgeon.
- H.-V. Gartner, C. Seidl, C. Luckenbach, G. Schumm, E. Seifried, H. Ritter, and B. Bultmann (1996)
N. Engl. J. Med.
335, 1494-1497
| Full Text »
| PDF »
- Molecular biology of the H-2 histocompatibility complex.
- R. Flavell, H Allen, L. Burkly, D. Sherman, G. Waneck, and G Widera (1986)
Science
233, 437-443
| Abstract »
| PDF »
|
|